# China NMPA Drug Inspection - Beijing Fuyuan Pharmaceutical Co., Ltd. - Moxifloxacin Hydrochloride Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/beijing-fuyuan-pharmaceutical-co-ltd/fdf19aed-bdce-494d-b39c-9428e90dc3ee/
Source feed: China

> China NMPA drug inspection for Beijing Fuyuan Pharmaceutical Co., Ltd. published June 05, 2020. Drug: Moxifloxacin Hydrochloride Tablets. The Beijing Municipal Drug Administration released its first-quarter 2020 report (Announcement No. 18) regarding drug qu

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Beijing Municipal Drug Administration's First Quarter 2020 Drug Quality and Safety Bulletin
- Company Name: Beijing Fuyuan Pharmaceutical Co., Ltd.
- Publication Date: 2020-06-05
- Drug Name: Moxifloxacin Hydrochloride Tablets
- Inspection Finding: Compliant
- Summary: The Beijing Municipal Drug Administration released its first-quarter 2020 report (Announcement No. 18) regarding drug quality and safety sampling inspections. Conducted under the city's 2020 Implementation Plan for Drug Quality Sampling Inspection, the audit targeted manufacturers, wholesalers, and retail headquarters. The inspection specifically reviewed ten batches of drugs critical for epidemic prevention and control. Key companies involved in the sampling included Beijing Yiling Pharmaceutical, Beijing Sanyuan Gene Pharmaceutical, Beijing Yuance Pharmaceutical, Beijing Kaiyin Technology, Juxiechang (Beijing) Pharmaceutical, Beijing Hanmei Pharmaceutical, Bayer Healthcare, and Beijing Fuyuan Pharmaceutical. The Beijing Municipal Institute for Drug Control evaluated the samples against the 2015 Chinese Pharmacopoeia and specific National Drug Standards. No violations or quality issues were found; all ten sampled batches were confirmed as compliant and qualified. Consequently, no corrective actions or penalties were required for the listed companies. The document serves as an official confirmation that the essential medical products sampled during this period met all safety and efficacy requirements.

Company: https://www.globalkeysolutions.net/companies/beijing-fuyuan-pharmaceutical-co-ltd/78baf398-8a99-4a59-af72-1da15316303a/